Suppression Of Bacterial Vaginosis (BV) [SUBVert]
NCT03930745
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
81
Enrollment
NIH
Sponsor class
Conditions
Bacterial Vaginosis
Interventions
OTHER:
Placebo
DRUG:
TOL-463
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)